Dr. Linden is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle Cancer Care Alliance
Seattle, WA 98109Phone+1 206-606-6989Fax+1 206-606-2054
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 1993 - 1994
- University of WashingtonFellowship, Medical Oncology, 1992 - 1994
- University of Massachusetts Medical SchoolClass of 1989
Certifications & Licensure
- WA State Medical License 1993 - 2025
- AZ State Medical License 1990 - 1994
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy Start of enrollment: 2010 Sep 15
- Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy Start of enrollment: 2021 Jul 10
Publications & Presentations
PubMed
- 4 citationsF-Labeled Fluoroestradiol PET/CT: Current Status, Gaps in Knowledge, and Controversies-Expert Panel Narrative Review.Matthew F Covington, Sophia R O'Brien, Courtney Lawhn-Heath, Austin R Pantel, Gary A Ulaner
AJR. American Journal of Roentgenology. 2024-10-01 - 3 citationsActivity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative a...Carlo Palmieri, Hannah Linden, Stephen N Birrell, Sally Wheelwright, Elgene Lim
The Lancet. Oncology. 2024-03-01 - Alcohol, Smoking, and Risks of Breast Cancer Recurrence and Mortality among Women with Luminal, Triple-Negative, and HER2-Overexpressing Breast Cancer.Nicole C Loroña, Megan Othus, Kathleen E Malone, Hannah M Linden, Mei-Tzu C Tang
Cancer Epidemiology, Biomarkers & Prevention. 2024-02-06
Journal Articles
- Test-Retest Reproducibility of FDG-PET/CT Uptake in Cancer Patients Within a Qualified and Calibrated Local NetworkJennifer M Specht, Jean H Lee, Hannah M Linden, Andrew T Shields, David A Mankoff, Paul E Kinahan, Journal of Nuclear Medicine
Press Mentions
- What’s New in Breast Cancer Research? SABCS 2022 Delivers PlentyDecember 14th, 2022
- Fred Hutch/UW Cancer Consortium Breast Cancer Researchers Receive GrantsNovember 17th, 2022
- 4 Advances in Breast Cancer Research You Should Know AboutSeptember 28th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: